Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating chronic bronchitis

A chronic bronchitis and drug technology, applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of unsatisfactory treatment effect, inconvenient carrying and taking, and high price, so as to reduce the treatment cost, low cost, and easy to take Effect

Inactive Publication Date: 2010-06-16
郑水灿
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine is expensive and has certain toxic and side effects. It is not ideal for the treatment of cough and asthma, which is prone to recurrent diseases.
In recent years, the number of domestically produced Chinese patent medicines has increased, but most traditional Chinese medicines need to be tortured, which is troublesome and inconvenient to carry and take

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1: A medicine for the treatment of chronic bronchitis, containing the following components in parts by weight: 50 to 80 parts of chrysanthemum, 30 to 60 parts of stomata, 40 to 60 parts of aster, 40 to 60 parts of loquat leaves , Gecko 20~45 parts, Coptis 20~45 parts, Honeysuckle 30~60 parts, Snake gall 15-25 parts, Mint 40~60 parts, Light bamboo leaves 60~90 parts, Bitter almonds 30~60 parts, Pipi 40~60 parts Servings, 50-60 servings of Fritillaria, 200-300 servings of pineapple juice.

[0032] The components are dried, ground and crushed together, and passed through a 100-mesh sieve to prepare the required pharmaceutical dosage form. The pharmaceutical dosage form is powder, or tablet, or pill, or granule, or capsule.

Embodiment 2

[0033] Example 2: The preparation method of the medicine of this example is the same as that of example 1. The similarities are not repeated, and the difference is: a medicine for treating chronic bronchitis, containing the following components in parts by weight: Chrysanthemum 80 parts, sternum 60 parts, aster 60 parts, loquat leaves 60 parts, geckos 45 parts, coptis 45 parts, honeysuckle 60 parts, snake gall 25 parts, peppermint 60 parts, light bamboo leaves 90 parts, bitter almonds 60 parts, pipi 60 parts Servings, 60 servings of Fritillaria, 300 servings of pineapple juice.

Embodiment 3

[0034] Example 3: The preparation method of the medicine of this example is the same as that of example 1. The similarities are not repeated, the difference is: a medicine for treating chronic bronchitis, containing the following components in parts by weight: Chrysanthemum 50 to 80 parts, 30 to 60 parts of sternum, 40 parts of aster, 40 parts of loquat leaves, 20 parts of geckos, 20 parts of coptis, 30 parts of honeysuckle, 15 parts of snake gall, 40 parts of mint, 60 parts of light bamboo leaves, 30 parts of bitter almonds , Pipi 40 parts, Fritillaria 50 parts, pineapple juice 200 parts.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating chronic bronchitis, which comprises the following components in part by weight: 50 to 80 parts of flos chrysanthemi, 30 to 60 parts of sessile stemona root, 40 to 60 parts of tatarian aster root, 40 to 60 parts of loquat leaf, 20 to 45 parts of tokay, 20 to 45 parts of golden thread, 30 to 60 parts of honeysuckle, 15 to 25 parts of snake gall, 40 to 60 parts of mint, 60 to 90 parts of common lophatherum herb, 30 to 60 parts of bitter almond kernel, 40 to 60 parts of tangerine peel, 50 to 60 parts of caladium and 200 to 300 parts of ananas comosus juice. Based on Chinese medicinal and pharmacologic theory, through years of clinical practice, the medicament for treating the chronic bronchitis is prepared from pure Chinese medicaments which are selected from Chinese medical treasury and have the effects of diminishing inflammation and relieving cough, dispelling itch and relieving asthma and moistening the lung and enriching the saliva, and has the good treatment effect on various kinds of chronic bronchitis, and particularly is suitable for patients with chronic cough and complication.

Description

1. Technical Field: [0001] The invention relates to a medicine, in particular to a medicine for treating chronic bronchitis, and belongs to the processing and preparation field of Chinese medicine. 2. Background technology: [0002] Chronic bronchitis is a common lung disease. Because there are many factors that induce the onset of cough and asthma, its incidence is extremely high, causing great suffering to patients and increasing the economic burden of patients. [0003] At present, although there are many drugs for the treatment of chronic bronchitis, most of them have average curative effect and small adaptation range. Western medicine treatment is expensive and has certain toxic and side effects, and the treatment effect for diseases that are prone to recurrent cough and asthma is not ideal. In recent years, domestically produced Chinese patent medicines have increased, but most Chinese medicines need to be tormented, cumbersome and inconvenient to carry and take. People exp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/904A61P11/00A61K35/58A61K35/56A61K35/583A61K35/644
Inventor 郑水灿
Owner 郑水灿
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products